Toshitsugu Sugimoto

Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis

Tetsuo Shoji, Masaaki Inaba, Masafumi Fukagawa et al. · JAMA · 2018 · 88 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis

Akira Itabashi, Kousei Yoh, Arkadi Chines et al. · Journal of Bone and Mineral Research · 2010 · 39 citations

Medicine, Pharmacotherapy, Bone Metabolism +12

Association between the risk of falls and osteoporotic fractures in patients with type 2 diabetes mellitus

Maki Yokomoto‐Umakoshi, Ippei Kanazawa, Shiori Kondo et al. · Endocrine Journal · 2017 · 37 citations · Full text

Medicine, Geriatric Medicine, Orthopedic Surgery +16

Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report

Ayumu Takeno, Masahiro Yamamoto, Masakazu Notsu et al. · BMC Endocrine Disorders · 2016 · 13 citations · Full text

Medicine, Endocrinology, Pathology +17